• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子在经放线菌素D处理的K562细胞中诱导形成细胞质小泡。

TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cells.

作者信息

Munker R, Greither L, Darsow M, Pander S, Wilmanns W

机构信息

Medizinische Klinik III im Klinikum Grosshadern der LMU, Munich, Federal Republik of Germany.

出版信息

Ann Hematol. 1992 Jul;65(1):50-2. doi: 10.1007/BF01715127.

DOI:10.1007/BF01715127
PMID:1643161
Abstract

We report here that tumor necrosis factor alpha (TNF) induces peculiar cytoplasmic vesicles in the human erythromyeloid leukemia cell line K 562, sensitized to the cytotoxic action of TNF by a treatment with the inhibitor of transcription actinomycin D. These vesicles are well delineated ultrastructurally. The formation of these vesicles is characteristic for the combination of actinomycin D with TNF and precedes the changes of apoptosis and cellular disintegration. These vesicles correspond to an intermediate step in the cytotoxicity caused by TNF and may indicate that reactive metabolites are involved in the mechanism of action of TNF.

摘要

我们在此报告,肿瘤坏死因子α(TNF)在经转录抑制剂放线菌素D处理而对TNF细胞毒性作用敏感的人红髓白血病细胞系K 562中诱导形成特殊的细胞质囊泡。这些囊泡在超微结构上界限清晰。这些囊泡的形成是放线菌素D与TNF联合作用的特征性表现,且先于细胞凋亡和细胞解体的变化。这些囊泡对应于TNF引起的细胞毒性作用中的一个中间步骤,可能表明活性代谢产物参与了TNF的作用机制。

相似文献

1
TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cells.肿瘤坏死因子在经放线菌素D处理的K562细胞中诱导形成细胞质小泡。
Ann Hematol. 1992 Jul;65(1):50-2. doi: 10.1007/BF01715127.
2
In vitro cytotoxicity of recombinant human-TNF-alpha and actinomycin D on canine normal and tumor cells.重组人肿瘤坏死因子-α和放线菌素D对犬正常细胞和肿瘤细胞的体外细胞毒性。
J Vet Med Sci. 1998 Oct;60(10):1087-91. doi: 10.1292/jvms.60.1087.
3
Effect of recombinant tumor necrosis factor on HL-60 cells: cell-cycle specificity and synergism with actinomycin D.重组肿瘤坏死因子对HL-60细胞的作用:细胞周期特异性及与放线菌素D的协同作用
J Cell Physiol. 1987 Mar;130(3):328-35. doi: 10.1002/jcp.1041300304.
4
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.在Apo2L/TRAIL介导的前列腺癌细胞凋亡过程中,通过与Apo2L/TRAIL和放线菌素D互补实现协同作用:XIAP在耐药中的作用
Prostate. 2002 Dec 1;53(4):286-99. doi: 10.1002/pros.10155.
5
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.肿瘤坏死因子相关凋亡诱导配体(TRAIL)与放线菌素D联合使用即使在对TRAIL耐药的人胰腺癌细胞中也能诱导细胞凋亡。
Clin Cancer Res. 2001 Feb;7(2):407-14.
6
A tumour necrosis factor-alpha (TNF-alpha) sensitive adherent KYM-1D4 derived cell line: use in TNF-alpha cytotoxicity assays in the presence of actinomycin D.一种对肿瘤坏死因子-α(TNF-α)敏感的贴壁KYM-1D4衍生细胞系:在放线菌素D存在的情况下用于TNF-α细胞毒性测定。
J Immunol Methods. 1999 Jul 30;227(1-2):197-8. doi: 10.1016/s0022-1759(99)00081-2.
7
Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycin.红霉素和肿瘤坏死因子对多药耐药细胞耐药性的影响:红霉素逆转耐药性
Int J Cancer. 1989 Mar 15;43(3):520-5. doi: 10.1002/ijc.2910430330.
8
An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line.一种内源性55 kDa肿瘤坏死因子受体介导神经细胞系中的细胞死亡。
Brain Res Mol Brain Res. 1996 Jun;38(2):222-32. doi: 10.1016/0169-328x(95)00310-o.
9
TNF-alpha-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin D.肿瘤坏死因子-α介导的经MG132或放线菌素D致敏的软骨细胞凋亡
Biochem Biophys Res Commun. 2002 Jul 26;295(4):937-44. doi: 10.1016/s0006-291x(02)00789-1.
10
Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines.重组肿瘤坏死因子:其对多种正常及转化的人细胞系的作用及其与γ干扰素的协同作用。
Eur J Cancer Clin Oncol. 1986 Apr;22(4):419-26. doi: 10.1016/0277-5379(86)90107-0.

本文引用的文献

1
[Myeloblastic leukemia. Cytochemistry, electron microscopy and cytogenetics].
Blut. 1971 Oct;23(4):189-206. doi: 10.1007/BF01633771.
2
Tumour necrosis factor.
Br J Haematol. 1988 Jun;69(2):149-52. doi: 10.1111/j.1365-2141.1988.tb07615.x.
3
In vitro action of tumor necrosis factor on myeloid leukemia cells.肿瘤坏死因子对髓系白血病细胞的体外作用。
Blood. 1987 Apr;69(4):1102-8.
4
Tumor necrosis factor: an update on basic research and clinical applications.
肿瘤坏死因子:基础研究与临床应用的最新进展
Klin Wochenschr. 1990 Sep 3;68(17):841-6. doi: 10.1007/BF01662779.
5
Cytotoxic mechanism of tumor necrosis factor-alpha.肿瘤坏死因子-α的细胞毒性机制
FASEB J. 1990 Nov;4(14):3215-23. doi: 10.1096/fasebj.4.14.2172061.
6
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.具有费城染色体阳性的人慢性粒细胞白血病细胞系。
Blood. 1975 Mar;45(3):321-34.